Investor Relations Press Releases 31 May 23 GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset 24 May 23 GENFIT: May 24, 2023 Combined Shareholders Meeting results 23 May 23 GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology View All
23 May 23 GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology
Video Replay - Interview of Pascal Prigent, CEO & Dean Hum, CSO at SVB Securities Global Biopharma Conference - February 15th, 2023
GENFIT - Corporate Presentation for Corporate Access and Biotech Showcase during JP Morgan Healthcare Conference - January 2023